Back to Journals » Cancer Management and Research » Volume 13

Corrigendum

Oridonin Sensitizes Hepatocellular Carcinoma to the Anticancer Effect of Sorafenib by Targeting the Akt Pathway [Corrigendum]

       
Total article views   HTML views PDF downloads Totals
2,648 Dovepress* 2,561+ 329 2,890
PubMed Central* 87 47 134
Totals 2,648 376 3,024
*Since 16 March 2021

View citations on PubMed Central and Google Scholar